Biomerieux reagents for bdaach, korea: FY 24 delivery order
Ended Awarded Last action
- Contract number
- W81K0224F0102
- Awardee
-
Chenkwang Science UEI M7HGNKTZLU73
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $30,587
Award facts
- Opportunity
-
- Biomerieux Reagents for Brian D. Allgood Army Community Hospital, Korea Pre-Solicitation · W81K0223Q0145 · Posted Jul 19, 2023
- Contract value 100% obligated
- $30,586.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$15,482 | |
| Funding Only Action | $46,069 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $30,586.50 firm fixed-price delivery order to Chenkwang Science for the provision of Biomerieux reagents to support the Biological Defense Analytical and Assessment Center (BDAACH) located in South Korea. The delivery order, effective October 1, 2024, extends through September 30, 2025, and represents one of two firm fixed-price delivery orders issued to the contractor under its larger Indefinite Delivery Contract valued at $232,645.53. Chenkwang Science, a for-profit organization registered in South Korea and specializing in medical and microbiological reagents, was selected as the prime contractor with no set-aside designation applied. The reagents supplied under this award support bacterial pathogen identification, antimicrobial resistance testing, and microbiological assessment capabilities at U.S. military medical treatment facilities in the Asia-Pacific region.
This delivery order falls under the Defense Health Agency's broader IDC with Chenkwang Science, which runs from October 1, 2023, through September 30, 2028, and includes a base year plus four one-year option periods. The contractor has demonstrated consistent capability in supplying diagnostic and analytical laboratory materials to DoD medical facilities in South Korea and Japan, with a contract history focused exclusively on delivering Biomerieux reagents and microbiology testing services. The place of performance is South Korea, and the contract utilizes firm fixed-price pricing to support critical military medical operations in the region.
Quick answers
Who was awarded contract W81K0224F0102?
W81K0224F0102 was awarded to Chenkwang Science by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0224F0102 worth?
The government has obligated $30,587 on W81K0224F0102.
Which agency awarded contract W81K0224F0102?
Medical Command (Department of the Army) awarded W81K0224F0102, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0102 an order under another contract?
Yes. W81K0224F0102 is a delivery order under W81K0223D0002, an indefinite delivery contract.
Was contract W81K0224F0102 competed?
The extent of competition for W81K0224F0102 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award